Kybella is a revolutionary FDA-approved injectable formulated with synthetic deoxycholic acid, a naturally occurring molecule found in the human digestive tract that breaks down and absorbs dietary fat
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations
Tolerability at the highest dose remains a limiting factor
Limit: retatrutide is newer, with fewer long-term data (phase III ongoing, not yet published), and the glucagon arm imposes stricter ALT/AST follow-up
For example, a Cleveland Clinic study from June 2025, involving 7,881 participants, found that high-dose tirzepatide users lost 18.0% of their body weight in one year, semaglutide users lost 13.7%, and those who discontinued early (within three months) lost just 3.6%
It works by reducing appetite and increasing feelings of fullness, which helps to decrease calorie intake